Literature DB >> 22159731

Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients.

S Akhlaghpoor1, A Ghahari, A Morteza, O Khalilzadeh, A Shakourirad, M R Alinaghizadeh.   

Abstract

BACKGROUND: Iron overload is a common clinical problem in patients with β-thalassemia major. The purpose of this study was to assess the presence of excess iron in certain areas of the brain (thalamus, midbrain, adenohypophysis and basal ganglia) in patients with β-thalassemia major and evaluate the association with serum ferritin and liver iron content.
MATERIALS AND METHODS: A cross-sectional study on 53 patients with β-thalassemia major and 40 healthy controls was carried out. All patients and healthy controls underwent magnetic resonance imaging (MRI) examinations of the brain and liver. Multiecho fast gradient echo sequence was used and T2* values were calculated based on the Brompton protocol. Correlations between T2* values in the brain with T2* values in the liver as well as serum ferritin levels were investigated.
RESULTS: There were no significant differences between patients and healthy controls with respect to age and sex. Patients had significantly lower T2* values in basal ganglia (striatum), thalamus and adenohypophysis compared to controls while there were no differences in the midbrain (red nucleus). There were no significant correlations between liver T2* values or serum ferritin with T2* values of basal ganglia (striatum), thalamus and adenohypophysis in patients or healthy controls. There were no significant correlations between T2* values of adenohypophysis and thalamus or basal ganglia (striatum) while these variables were significantly correlated in healthy controls.
CONCLUSIONS: Serum ferritin and liver iron content may not be good indicators of brain iron deposition in patients with β thalassemia major. Nevertheless, the quantitative T2* MRI technique is useful for evaluation of brain iron overload in β thalassemia major patients.

Entities:  

Mesh:

Year:  2011        PMID: 22159731     DOI: 10.1007/s00062-011-0108-z

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  26 in total

1.  T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major.

Authors:  M I Argyropoulou; Z Metafratzi; D N Kiortsis; S Bitsis; A Tsatsoulis; S Efremidis
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

2.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

3.  Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine.

Authors:  Lisa J Anderson; Mark A Westwood; Emma Prescott; J Malcolm Walker; Dudley J Pennell; Beatrix Wonke
Journal:  Acta Haematol       Date:  2006       Impact factor: 2.195

4.  Improved T2* assessment in liver iron overload by magnetic resonance imaging.

Authors:  Vincenzo Positano; Benedetta Salani; Alessia Pepe; Maria Filomena Santarelli; Daniele De Marchi; Anna Ramazzotti; Brunella Favilli; Eliana Cracolici; Massimo Midiri; Paolo Cianciulli; Massimo Lombardi; Luigi Landini
Journal:  Magn Reson Imaging       Date:  2008-07-30       Impact factor: 2.546

5.  Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens.

Authors:  Nilesh R Ghugre; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

6.  Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.

Authors:  Lisa J Anderson; Mark A Westwood; Sally Holden; Bernard Davis; Emma Prescott; Beatrix Wonke; John B Porter; J Malcolm Walker; Dudley J Pennell
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

7.  Mimicking liver iron overload using liposomal ferritin preparations.

Authors:  John C Wood; Joe D Fassler; Tom Meade
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

8.  Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.

Authors:  C Roth; A Pekrun; M Bartz; H Jarry; S Eber; M Lakomek; W Schröter
Journal:  Eur J Pediatr       Date:  1997-10       Impact factor: 3.183

9.  T2 shortening in the motor cortex: effect of aging and cerebrovascular diseases.

Authors:  T Hirai; Y Korogi; Y Sakamoto; S Hamatake; I Ikushima; M Takahashi
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

10.  Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome.

Authors:  J E Nielsen; L N Jensen; K Krabbe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

View more
  10 in total

1.  Restless legs syndrome/Willis-Ekbom disease prevalence in beta thalassemia patients.

Authors:  Euthimia Dimitriadou; Christoforos D Giannaki; Maria Tsekoura; Ioannis Stefanidis; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Sleep Breath       Date:  2017-04-19       Impact factor: 2.816

2.  RANK/RANKL/OPG axis genes relation to cognitive impairment in children with transfusion-dependent thalassemia: a cross-sectional study.

Authors:  Suzan Omar Mousa; Asmaa Hosni Abd El-Hafez; Mostafa Ahmed Abu El-Ela; Mohamed Aboul-Fotouh Mourad; Rasha Nady Saleh; Samira Zain Sayed
Journal:  BMC Pediatr       Date:  2022-07-20       Impact factor: 2.567

3.  Imaging of Central Nervous System Involvement in Pediatric Hematologic Disorders.

Authors:  Sevinç Kalın; Korgün Koral
Journal:  Turk Arch Pediatr       Date:  2022-05

4.  Absence of T1 Hyperintensity in the Brain of High-risk Patients After Multiple Administrations of High-dose Gadobutrol for Cardiac Magnetic Resonance.

Authors:  Antonella Meloni; Domenico Montanaro; Daniele De Marchi; Mariachiara Resta; Petra Keilberg; Laura Pistoia; Vincenzo Positano; Anna Spasiano; Tommaso Casini; Caterina Cinzia De Bari; Sara De Cori; Alessia Pepe
Journal:  Clin Neuroradiol       Date:  2020-03-17       Impact factor: 3.649

5.  Quantitative T1, T2, and T2* Mapping and Semi-Quantitative Neuromelanin-Sensitive Magnetic Resonance Imaging of the Human Midbrain.

Authors:  Takashi Hashido; Shigeyoshi Saito
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

6.  Acinetobacter baumannii Infection in Transfusion Dependent Thalassemia Patients with Sepsis.

Authors:  Faisal Mousa Alzahrani; Saeed Sattar Shaikh
Journal:  Biomed Res Int       Date:  2017-05-17       Impact factor: 3.411

7.  An investigation of age-related iron deposition using susceptibility weighted imaging.

Authors:  Dan Wang; Wen-Bin Li; Xiao-Er Wei; Yue-Hua Li; Yong-Ming Dai
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Investigation of cerebral iron deposition in aged patients with ischemic cerebrovascular disease using susceptibility-weighted imaging.

Authors:  Yin Liu; Jun Liu; Huanghui Liu; Yunjie Liao; Lu Cao; Bin Ye; Wei Wang
Journal:  Ther Clin Risk Manag       Date:  2016-08-16       Impact factor: 2.423

9.  Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study.

Authors:  Renzo Manara; Sara Ponticorvo; Immacolata Tartaglione; Gianluca Femina; Andrea Elefante; Camilla Russo; Pasquale Alessandro Carafa; Mario Cirillo; Maddalena Casale; Angela Ciancio; Rosanna Di Concilio; Elisa De Michele; Nikolaus Weiskopf; Francesco Di Salle; Silverio Perrotta; Fabrizio Esposito
Journal:  Neuroimage Clin       Date:  2019-10-25       Impact factor: 4.881

10.  Neuroimaging Findings in Pediatric Patients with Thalassemia Major.

Authors:  Yılmaz Akbaş; Sultan Aydın; Gökçen Öz Tunçer; Alper Köker; Yasemin Çoban; Gönül Oktay; Hakan Yeral
Journal:  Hematol Rep       Date:  2022-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.